Additionally, in this context, p53 modulates the expression of different lncRNAs, thus revealing a p53-lncRNA tumor suppressor signature that characterizes CLL pathogenesis [97,98]. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.